There’s a shortage of EpiPens in Canada right now due to a manufacturing disruption at pharmaceutical provider Pfizer Canada.
EpiPen auto-injectors in the 0.3 mg format are the products in deficit, and will likely remain to be throughout the entire winter. Pfizer Canada is currently working distributors and hopes to resolve the shortage by March 2, 2018.
EpiPens are used as an emergency measure to treat life-threatening allergic reactions. They administer adrenaline (epinephrine) to combat the anaphylaxis that can result in individuals with severe allergies.
As of now, the shortage is expected to last a two- to four-month period, with a very limited inventory to be made available at the start of February. In the meantime, Health Canada has suggested that Canadians in need of EpiPens resort to expired ones in the event of an emergency and to call 911 immediately.
EpiPen auto-injectors only expire on the last day of the month indicated on the product. This means that if an EpiPen is expiring in January, it remains safe to use until January 31.
To stay updated with the status of this medication, visit drugshortagescanada.ca.